Patent directory Β· USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 7201911
Cloned genomes of infectious hepatitis C viruses and uses thereof
granted -
DE 102005046769
Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus)
granted -
US 7198788
Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26.
granted -
US 7199124
JNK inhibitor
granted -
US 7198949
Compositions and methods for altering the biodistribution of biological agents
granted -
US 7199223
Polymer-factor VIII moiety conjugates
granted -
US 7198947
Production of functional proteins: balance of shear stress and gravity
granted -
US 7199157
Use of treprostinil to improve kidney functions
granted -
US 7198783
Sensitization of neoplastic cells to radiation therapy with reovirus
granted -
US 7199114
Triterpene quaternary salts as biologically active surfactants
granted -
US 7199102
Orally administered peptides synergize statin activity
granted -
US 7199127
Purine nucleosides
granted -
US 7199103
Synthetic compounds and compositions with enhanced cell binding
granted -
US 7196184
Double-stranded RNA (DSRNA) and method of use for inhibiting expression of the AML-1/MTG8 fusion gene
granted -
US 7196222
Sertraline hydrochloride form II and methods for the preparation thereof
granted -
US 7196205
Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
granted -
US 7195778
Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
granted -
US 7195911
Mammalian cells that have increased proliferative capacity
granted -
US 7196074
Methods of making, using and pharmaceutical formulations comprising 7Ξ±, 11Ξ²-dimethyl-17Ξ²-hydroxyestra-4, 14-dien-3-one and 17 esters thereof
granted -
US 7196119
Development of new selective estrogen receptor modulators
granted -
US 7195768
Polyvalent immunogen
granted -
US 7195876
Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same
granted -
US 7196098
Quinuclidine derivatives and medicinal compositions containing the same
granted -
WO 2007031520
UTILISATION DE DICHLORHYDRATE D'OCTENIDINE DANS DES PREPARATIONS SEMI-SOLIDES
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β best for looking up a specific filing or applicant portfolio slice.